We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
MedXY AI/MedXY News/Gastroenterology

Gastroenterology

Ask MedXY AI
What is the latest evidence?Key clinical updatesGuideline changes

Latest news

Surveillance Colonoscopy in Lynch Syndrome: Impact on Colorectal Cancer Outcomes in a National NHS Cohort
GastroenterologyCancer MortalityColonoscopy surveillance

Surveillance Colonoscopy in Lynch Syndrome: Impact on Colorectal Cancer Outcomes in a National NHS Cohort

By MedXY|Aug 11, 2026

This national NHS cohort study evaluates how adherence to colonoscopy surveillance affects colorectal cancer incidence and mortality among Lynch syndrome patients, revealing decreased mortality despite unchanged incidence, raising implicati

Liver, Portal, and Systemic Thyroid Hormone Alterations in End-Stage MASH: Distinct Diagnostic and Prognostic Roles for T3/rT3 Ratio and T4
Clinical Updatesthyroid hormone metabolismResmetirom

Liver, Portal, and Systemic Thyroid Hormone Alterations in End-Stage MASH: Distinct Diagnostic and Prognostic Roles for T3/rT3 Ratio and T4

By MedXY|Aug 11, 2026

End-stage metabolic dysfunction-associated steatohepatitis (MASH) features profound disruptions in thyroid hormone metabolism across liver, portal, and systemic compartments, with the hepatic T3 level and systemic T3/rT3 ratio serving as se

Genomic Profiling of Primary Gastric Tumors Predicts Recurrence Patterns and Survival Outcomes
Gastroenterologytumor genomicsrecurrence

Genomic Profiling of Primary Gastric Tumors Predicts Recurrence Patterns and Survival Outcomes

By MedXY|Aug 9, 2026

Genomic alterations in primary gastric tumors, including KRAS and PIK3CA mutations, correlate with recurrence risk and metastatic patterns, informing personalized postoperative surveillance and treatment strategies.

Robotic Whole-Graft Liver Transplantation: Insights from 45 Cases and Benchmark Outcome Analysis
GastroenterologyRobotic liver transplantationwhole-graft liver transplant

Robotic Whole-Graft Liver Transplantation: Insights from 45 Cases and Benchmark Outcome Analysis

By MedXY|Aug 9, 2026

This study evaluates the safety and efficacy of robotic whole-graft liver transplantation (RLT) in 44 patients, demonstrating benchmark-level perioperative outcomes with a focus on operative time improvement through the learning curve in sp

BEACON-HCC: A North American consensus reshaping treatment allocation for hepatocellular carcinoma
GastroenterologyBEACON-HCClocoregional therapy

BEACON-HCC: A North American consensus reshaping treatment allocation for hepatocellular carcinoma

By MedXY|Aug 9, 2026

BEACON-HCC is a multidisciplinary, evidence-based North American consensus that updates HCC treatment allocation—integrating tumor biology, nuanced intrahepatic burden, vascular invasion, and newer modalities (EBRT, TARE, systemic–locoregio

Extracellular Vesicles as Liquid Biopsy Biomarkers Predicting Immune Checkpoint Therapy Resistance in Hepatocellular Carcinoma
Gastroenterologyimmune checkpoint inhibitorsimmunotherapy resistance

Extracellular Vesicles as Liquid Biopsy Biomarkers Predicting Immune Checkpoint Therapy Resistance in Hepatocellular Carcinoma

By MedXY|Aug 9, 2026

Circulating extracellular vesicles carrying PD-1, PD-L1, and CTLA-4 can non-invasively predict responses and early resistance to immune checkpoint inhibitors in advanced hepatocellular carcinoma, improving patient stratification and managem

Sex-Based Disparities in Surgical Opportunities During Early Adoption of Robot-Assisted Surgery
GastroenterologySex Disparitiesoperative opportunities

Sex-Based Disparities in Surgical Opportunities During Early Adoption of Robot-Assisted Surgery

By MedXY|Aug 6, 2026

This study reveals significant sex-based disparities in access to robot-assisted surgery operative experience, showing female surgeons perform fewer robot-assisted procedures than males, potentially impacting career progression.

Enhancing Hepatitis B Treatment: Pegylated Interferon After Nucleos(t)ide Withdrawal Boosts HBsAg Loss in HBeAg-Negative Patients
GastroenterologyHBsAg lossNucleos(t)ide analogue withdrawal

Enhancing Hepatitis B Treatment: Pegylated Interferon After Nucleos(t)ide Withdrawal Boosts HBsAg Loss in HBeAg-Negative Patients

By MedXY|Aug 7, 2026

Adjuvant pegylated interferon following nucleos(t)ide analogue withdrawal in HBeAg-negative chronic hepatitis B significantly increases HBsAg loss rates and reduces severe hepatic flares over three years compared to withdrawal alone.

Subtype-Specific Enteric Neuronal Activation in IBS: Linking Faecal Proteases and Immune Signatures
Gastroenterologyenteric nervous systemIrritable Bowel Syndrome

Subtype-Specific Enteric Neuronal Activation in IBS: Linking Faecal Proteases and Immune Signatures

By MedXY|Aug 6, 2026

This study elucidates how faecal proteases and immune proteins distinctly activate enteric neurons in IBS subtypes, revealing subtype-specific pathological mechanisms and potential diagnostic biomarkers, highlighting novel therapeutic targe

Liver Stiffness Measurements as Prognostic Tools in Primary Sclerosing Cholangitis: Insights from the Prospective FICUS Cohort
Gastroenterologyviêm ống mật xơ cứng nguyên phátliver stiffness measurement

Liver Stiffness Measurements as Prognostic Tools in Primary Sclerosing Cholangitis: Insights from the Prospective FICUS Cohort

By MedXY|Aug 7, 2026

This prospective study confirms that liver stiffness measurements by Fibroscan® strongly predict transplant-free survival in primary sclerosing cholangitis patients, validating both static values and dynamic changes as vital prognostic mark

Disentangling Weight Loss-Dependent and Independent Effects of Survodutide on Liver Outcomes in MASH: Insights from a Phase 2 Mediation Analysis
Diabetes & EndocrinologyMASHMediation Analysis

Disentangling Weight Loss-Dependent and Independent Effects of Survodutide on Liver Outcomes in MASH: Insights from a Phase 2 Mediation Analysis

By MedXY|Aug 4, 2026

This mediation analysis of a phase 2 MASH trial reveals that survodutide improves liver inflammation and fibrosis predominantly through weight-independent mechanisms, highlighting a potential direct hepatic effect beyond weight reduction.

Rapid Skeletal Muscle Loss in Cirrhosis: Predictors, Outcomes, and Implications for Clinical Management
GastroenterologycirrhosisSarcopenia

Rapid Skeletal Muscle Loss in Cirrhosis: Predictors, Outcomes, and Implications for Clinical Management

By MedXY|Aug 4, 2026

Rapid skeletal muscle loss occurs in a significant subset of cirrhosis patients and independently predicts waitlist mortality, highlighting sarcopenia as a critical therapeutic target in liver disease management.

Acute Colonic Ischemia Following Elective Colectomy for Cancer: Risk Factors, Procedural Associations, and Outcomes
Clinical Updatescolectomycolonic ischemia

Acute Colonic Ischemia Following Elective Colectomy for Cancer: Risk Factors, Procedural Associations, and Outcomes

By MedXY|Aug 2, 2026

Postoperative colonic ischemia is a rare but severe complication after colectomy for colorectal cancer, primarily linked to specific resection types and vascular comorbidities, significantly impacting patient morbidity and mortality.

RIPPLY1 as a Guardian Against Cancer Stemness in CTNNB1-Mutated Hepatocellular Carcinoma
GastroenterologyCancer StemnessCTNNB1 mutation

RIPPLY1 as a Guardian Against Cancer Stemness in CTNNB1-Mutated Hepatocellular Carcinoma

By MedXY|Jul 31, 2026

RIPPLY1 suppresses cancer stemness by targeting TBX19, improving prognosis in CTNNB1-mutated hepatocellular carcinoma through inhibition of tumor progression.

Proteomic Insights into MASLD: Sex-Specific Endotypes and Predictive Value for Mortality
Diabetes & EndocrinologyMASLDmetabolic liver disease

Proteomic Insights into MASLD: Sex-Specific Endotypes and Predictive Value for Mortality

By MedXY|Jul 31, 2026

A large-scale proteomic study identified distinct MASLD subtypes influenced by sex differences and developed a four-protein score predicting all-cause mortality, advancing personalized risk assessment beyond traditional liver-centric models

Revolutionizing Stage II Colorectal Cancer Prognostication: Validating Semantically-Enhanced AI for Risk Stratification
Gastroenterologyprognostic biomarkersdeep learning

Revolutionizing Stage II Colorectal Cancer Prognostication: Validating Semantically-Enhanced AI for Risk Stratification

By MedXY|Aug 4, 2026

A novel AI model, SÉMIL, integrating vision-language and multiple instance learning, improves prognostic accuracy for stage II colorectal cancer by refining risk stratification beyond current clinical assessments, especially within NCCN hig

Improved Survival in Unresectable Hepatocellular Carcinoma with Combined Transarterial Chemoembolization and Thermal Ablation: Insights from the Phase 3 TORCH Trial
Gastroenterologyhepatocellular carcinomarandomized clinical trial

Improved Survival in Unresectable Hepatocellular Carcinoma with Combined Transarterial Chemoembolization and Thermal Ablation: Insights from the Phase 3 TORCH Trial

By MedXY|Jul 30, 2026

The phase 3 TORCH trial demonstrates that adding selective radiofrequency ablation after transarterial chemoembolization significantly improves progression-free and overall survival in patients with unresectable liver-confined hepatocellula

New Obesity Definitions Reclassify Many MASLD Patients but Do Not Improve Liver Risk Prediction
GastroenterologyMASLDliver-related events

New Obesity Definitions Reclassify Many MASLD Patients but Do Not Improve Liver Risk Prediction

By MedXY|Jul 28, 2026

New obesity definitions reclassify many MASLD patients as obese but do not improve prediction of liver-related events over BMI alone, according to a multinational cohort study.

Can a smartphone app replace in-person hypnotherapy for IBS? Trial finds non-inferiority not demonstrated, but response rates suggest a viable alternative
GastroenterologyIBSrandomized controlled trial

Can a smartphone app replace in-person hypnotherapy for IBS? Trial finds non-inferiority not demonstrated, but response rates suggest a viable alternative

By MedXY|Jul 28, 2026

A multicentre RCT found that smartphone-based self-guided hypnotherapy did not meet non-inferiority to in-person therapy for IBS abdominal pain, though both hypnotherapy arms outperformed psychoeducation.

Immediate Endoscopic Necrosectomy Shortens Recovery Time in Necrotizing Pancreatitis Without Increasing Complications
Gastroenterologyendoscopic necrosectomyrandomized controlled trial

Immediate Endoscopic Necrosectomy Shortens Recovery Time in Necrotizing Pancreatitis Without Increasing Complications

By MedXY|Jul 26, 2026

The WONDER-01 trial found that immediate endoscopic necrosectomy after drainage for necrotizing pancreatitis reduced median time to clinical success by 15 days compared to a step-up approach, with similar adverse events.

Prev
5 / 25
1…34567…25
Next
Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
Intimate Health
What Makes a Woman "Physiologically Addicted" Is Never Money, But These Two Relationship Qualities

Browse by specialty

Open language-specific specialty feeds and department pages.

news6629 articlesCardiology1375 articlesClinical Updates1288 articlesOncology1139 articlesDiabetes & Endocrinology842 articlesNeurology820 articlesPublic Health595 articlesGastroenterology572 articles
Hematology-Oncology
487 articles
Pediatrics484 articles
Internal Medicine444 articles